Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression.
Journal
Biomaterials science
ISSN: 2047-4849
Titre abrégé: Biomater Sci
Pays: England
ID NLM: 101593571
Informations de publication
Date de publication:
25 Oct 2022
25 Oct 2022
Historique:
pubmed:
14
9
2022
medline:
27
10
2022
entrez:
13
9
2022
Statut:
epublish
Résumé
Exogenously delivered mRNA-based drugs are emerging as a new class of therapeutics with the potential to treat several diseases. Over the last decade, advancements in the design of non-viral delivery tools have enabled mRNA to be evaluated for several therapeutic purposes including protein replacement therapies, gene editing, and vaccines. However,
Substances chimiques
RNA, Messenger
0
Pharmaceutical Preparations
0
Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM